Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586–4588.

    Article  CAS  Google Scholar 

  2. Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009; 146: 310–316.

    Article  CAS  Google Scholar 

  3. Platzbecker U, Bornhauser M, Germing U, Stumpf J, Scott BL, Kroger N et al. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant 2008; 14: 1217–1225.

    Article  CAS  Google Scholar 

  4. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008; 42: 799–805.

    Article  CAS  Google Scholar 

  5. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303–1306.

    Article  Google Scholar 

  6. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T . Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 2001; 113: 836–838.

    Article  CAS  Google Scholar 

  7. Porter JB, Jaswon MS, Huehns ER, East CA, Hazell JW . Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage. Br J Haematol 1989; 73: 403–409.

    Article  CAS  Google Scholar 

  8. Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 852–860.

    Article  CAS  Google Scholar 

  9. Eberhard Y, McDermott SP, Wang X, Gronda M, Venugopal A, Wood TE et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 2009; 114: 3064–3073.

    Article  CAS  Google Scholar 

  10. Fukushima T, Kawabata H, Nakamura T, Iwao H, Nakajima A, Miki M et al. Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia. Anticancer Res 2011; 31: 1741–1744.

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded in part by the Jock and Bunny Adams Research and Education Endowment, and the National Institutes of Health, CA142106-06. PA is a recipient of a Special Fellowship in Clinical Research from the Leukemia and Lymphoma Society, a Career Development Award from the Conquer Cancer/ASCO Foundation, and a Scholar Award from the American Society of Hematology. PA and EJN have received research funding from Novartis, and EJN has also received research funding from FerroKin Biosciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Armand.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Armand, P., Sainvil, MM., Kim, H. et al. Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT. Bone Marrow Transplant 48, 146–147 (2013). https://doi.org/10.1038/bmt.2012.94

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.94

This article is cited by

Search

Quick links